Cargando…

Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties

When several Helicobacter pylori eradication treatments fail, guidelines recommend a cultured guided approach; however, culture is not widely available. Therefore, a rifabutin based regimen could be the best solution. Rifabutin indeed shows a low rate of antibiotic resistance. Rifabutin is generally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borraccino, Antonia Valeria, Celiberto, Francesca, Pricci, Maria, Girardi, Bruna, Iannone, Andrea, Rendina, Maria, Ierardi, Enzo, Di Leo, Alfredo, Losurdo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753051/ https://www.ncbi.nlm.nih.gov/pubmed/36533106 http://dx.doi.org/10.3748/wjg.v28.i45.6356

Ejemplares similares

Estrogen Receptors in Colorectal Cancer: Facts, Novelties and Perspectives
por: Ditonno, Ilaria, et al.
Publicado: (2021)

The State of the Art of Molecular Fecal Investigations for Helicobacter pylori (H. pylori) Antibiotic Resistances
por: Celiberto, Francesca, et al.
Publicado: (2023)

Role of concomitant therapy for Helicobacter pylori eradication: A technical note
por: Losurdo, Giuseppe, et al.
Publicado: (2016)

Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
por: Ierardi, Enzo, et al.
Publicado: (2019)

Fibres and Colorectal Cancer: Clinical and Molecular Evidence
por: Celiberto, Francesca, et al.
Publicado: (2023)

Comments regarding use of rifabutin for Helicobacter pylori eradication
por: Graham, David Y.
Publicado: (2021)

Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2022)

Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

Curcumin and Colorectal Cancer: From Basic to Clinical Evidences
por: Pricci, Maria, et al.
Publicado: (2020)

New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study
por: Iannone, Andrea, et al.
Publicado: (2018)

Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model
por: Girardi, Bruna, et al.
Publicado: (2020)

Helicobacter pylori Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial
por: Kalfus, Ira N., et al.
Publicado: (2020)

Characteristics and predictors of gastric cancer after Helicobacter pylori eradication
por: Shichijo, Satoki, et al.
Publicado: (2018)

Risk of gastric cancer development after eradication of Helicobacter pylori
por: Cheung, Ka-Shing, et al.
Publicado: (2018)

Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
por: Navarro-Jarabo, José M, et al.
Publicado: (2007)

Fondaparinux: A cornerstone drug in acute coronary syndromes
por: Khan, Mohammed Yunus, et al.
Publicado: (2022)

Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis
por: Ditonno, Ilaria, et al.
Publicado: (2023)

Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
por: Ierardi, Enzo, et al.
Publicado: (2017)

Generalizable items of quantitative and qualitative cornerstones for personnel requirement of physicians in anesthesia
por: Weiss, Manfred, et al.
Publicado: (2017)

Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
por: Gisbert, Javier P.
Publicado: (2020)

A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”
por: Losurdo, Giuseppe, et al.
Publicado: (2016)

Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)

Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Helicobacter pylori infection: Beyond gastric manifestations
por: Santos, Maria Luísa Cordeiro, et al.
Publicado: (2020)

Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2023)

Role of non-Helicobacter pylori gastric Helicobacters in helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma
por: Lemos, Fabian Fellipe Bueno, et al.
Publicado: (2023)

Helicobacter pylori virulence genes
por: Šterbenc, Anja, et al.
Publicado: (2019)

The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science
por: Ierardi, Enzo, et al.
Publicado: (2020)

Pathogenesis and clinical management of Helicobacter pylori gastric infection
por: de Brito, Breno Bittencourt, et al.
Publicado: (2019)

Helicobacter pylori in ancient human remains
por: Maixner, Frank, et al.
Publicado: (2019)

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen
por: Inokuchi, Kazumi, et al.
Publicado: (2022)

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)
por: Nyssen, Olga P., et al.
Publicado: (2022)

Helicobacter pylori Diversity and Gastric Cancer Risk
por: Cover, Timothy L.
Publicado: (2016)

Role of dupA in virulence of Helicobacter pylori
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2016)

Treatment of Helicobacter pylori infection in atrophic gastritis
por: Lahner, Edith, et al.
Publicado: (2018)

Infections with Helicobacter pylori and challenges encountered in Africa
por: Smith, Stella, et al.
Publicado: (2019)

Impact of Helicobacter pylori infection on gut microbiota
por: Iino, Chikara, et al.
Publicado: (2021)

Probiotics and autoprobiotics for treatment of Helicobacter pylori infection
por: Baryshnikova, Natalia V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k6gbv5q56htc6ffivg4ctrmcjt